Global Flow Cytometry Market

Flow Cytometry Market Size, Share, Growth Analysis, By Technology (Cell-Based, Bead-Based), Product & Service (Instruments, Software), Application (Research, Immunology), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2031 | Region: Global | Published Date: August, 2024
Pages: 157 | Tables: 130 | Figures: 77

Flow Cytometry Market Insights

Global Flow Cytometry Market size was valued at USD 3.97 Billion in 2022 and is poised to grow from USD 4.25 Billion in 2023 to USD 6.99 Billion by 2031, growing at a CAGR of 7.17% in the forecast period (2024-2031). 

Growth in the industry is attributed to increasing cancer instances, immune system disorders, and infections. High demand for flow cytometry instruments is also due to increased spending on R&D in the biotechnology, life science, and biopharmaceutical industries. Microfluidic flow cytometry for Point-of-Care (POC) testing is an example of the new and enhanced analytical tools that have emerged due to advancement in the technique.

Consequently, the COVID-19 epidemic has led to the growth of flow cytometry. Because of the enhanced accuracy and the number of specimens analyzed per time, the approach offers an opportunity to replace COVID-19 testing because it can avoid the limitations of the current PCR- or antibody-based testing solutions. Therefore, the sector has grown due to the use of flow cytometry approaches in diagnosing COVID-19 and monitoring the disease. The appearance of new products in this area also proves that, despite the pandemic, there are innovations in the field of flow cytometry.

The test uses flow cytometry to reveal important characteristics of a patient’s response to COVID-19 antigens and to make sound management decisions. What is more, it is expected that the adoption of such innovations would promote industry development in the future. The other factor that has influenced the adoption of flow cytometry techniques is the rising incidence of infectious diseases around the world. It is therefore necessary to look for viable substitute methods of immunophenotyping & cell isolation so as to combat these diseases, which annually claim more than 4. 5 million fatalities. This approach can be used to detect pathogenic microorganisms from environmental samples and may serve as a viable immunophenotyping method.

US Flow Cytometry Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Flow Cytometry Market size was valued at USD 3.97 Billion in 2022 and is poised to grow from USD 4.25 Billion in 2023 to USD 6.99 Billion by 2031, growing at a CAGR of 7.17% in the forecast period (2024-2031). 

The flow cytometry market is considered highly consolidated due to the presence of very few players in the market. These players are holding a huge share of the market and are likely to remain in a similar competitive environment for the next few years. Key market players in the market are Becton, Dickinson and Company, Danaher Corporation Sysmex Corporation, Bio-Rad Laboratories Inc, Luminex Corporation, etc. 'Becton, Dickinson, and Company (US) ', 'Danaher Corporation (US) ', 'Thermo Fisher Scientific, Inc. (US) ', 'Agilent Technologies, Inc. (US) ', 'Sony Group Corporation (Japan) ', 'Bio-Rad Laboratories, Inc. (US) ', 'Miltenyi Biotec GmbH (Germany) ', 'Enzo Biochem, Inc. (US) ', 'Sysmex Corporation (Japan) ', 'bioMérieux S.A. (France) ', 'Cytonome/ ST, LLC (US) ', 'Sartorius AG (Germany) ', 'Cytek Biosciences, Inc. (US) ', 'Union Biometrica, Inc. (US) ', 'Fluxion Biosciences, Inc. (US) ', 'Apogee Flow Systems Ltd. (UK) ', 'Merck KGaA (Germany) ', 'Beckman Coulter, Inc. (US) ', 'Stratedigm, Inc. (US) ', 'Nanocellect Biomedical (US)'

Flow cytometry faces a market restraint due to limited accessibility in resource-poor settings. Developing regions often lack the infrastructure and trained personnel required to operate and maintain these sophisticated instruments. This gap restricts the widespread adoption and utilization of flow cytometry, impeding its potential market growth and the ability to deliver advanced diagnostic and research capabilities in underfunded healthcare systems.

Flow cytometry is considered as an excellent tool for characterizing, identifying, and isolating stem cells for research and potential clinical applications. Recent advances in flow cytometric hardware, reagents, and software have enabled stem cell biologists to more fully identify and isolate rare cells. With such widespread use of flow cytometry for disease diagnosis and early detection, adoption in stem cell research is propelling the growth of the flow cytometry market. 

North America led the market with a 41.20% revenue share in 2023, driven by a robust healthcare system and pharmaceutical sector in the U.S., generating high demand for flow cytometry in clinical and research applications. Extensive R&D in therapeutics and increased public-private investments in cancer research have further boosted the need for these instruments. For instance, in December 2023, AlleSense was commissioned to advance cancer diagnostics using cutting-edge technologies, with an initial investment of around USD 2.5 million, significantly contributing to market growth.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Flow Cytometry Market

Report ID: SQMIG35H2031

$5,300
BUY NOW GET FREE SAMPLE